The table below shows Ventyx Biosciences, Inc.'s cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2025
Q1 2024
Q1 2023
Q1 2022
Q1 2021
Operating cash flow
-$25.72M
-$47.63M
-$30.92M
-$12.73M
-$3.02M
Capital expenditure
$16.00K
$175.00K
$60.00K
$38.00K
-
Investing cash flow
$26.41M
$41.77M
-$18.89M
-$16.50M
$1.90M
Dividends paid
-
-
-
-
-
Stock buybacks
-
-
VTYX operating cash flow (10-K history)
Ventyx Biosciences, Inc. reported operating cash flow of -$130.87M for fiscal year 2024. That is up 21.4% from -$166.52M in fiscal 2023. Over the 5 fiscal years shown, operating cash flow declined from -$6.20M (FY 2020) to -$130.87M. Figures come from the company's audited annual reports as filed with the SEC.